This test is a critical part of the panel for Antiphospholipid Syndrome (APS) and is used to detect an active or recent autoimmune response. It measures the IgM "first responder" antibodies that attack your body's own cardiolipins. A positive IgM result, often along with IgG, signals that your immune system is currently involved in creating a high-risk state for blood clots.